These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 29024552)
1. Current pharmacotherapies for obesity: A practical perspective. Golden A J Am Assoc Nurse Pract; 2017 Oct; 29(S1):S43-S52. PubMed ID: 29024552 [TBL] [Abstract][Full Text] [Related]
2. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis. Khera R; Murad MH; Chandar AK; Dulai PS; Wang Z; Prokop LJ; Loomba R; Camilleri M; Singh S JAMA; 2016 Jun; 315(22):2424-34. PubMed ID: 27299618 [TBL] [Abstract][Full Text] [Related]
3. Review of pharmacotherapy options for the management of obesity. Bragg R; Crannage E J Am Assoc Nurse Pract; 2016 Feb; 28(2):107-15. PubMed ID: 26119641 [TBL] [Abstract][Full Text] [Related]
4. Pharmacotherapy for obesity in individuals with type 2 diabetes. Chukir T; Shukla AP; Saunders KH; Aronne LJ Expert Opin Pharmacother; 2018 Feb; 19(3):223-231. PubMed ID: 29376439 [TBL] [Abstract][Full Text] [Related]
6. Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand? Tak YJ; Lee SY Curr Obes Rep; 2021 Mar; 10(1):14-30. PubMed ID: 33410104 [TBL] [Abstract][Full Text] [Related]
7. Obesity Epidemic: Pharmaceutical Weight Loss. Curry SA R I Med J (2013); 2017 Mar; 100(2):18-20. PubMed ID: 28246654 [TBL] [Abstract][Full Text] [Related]
8. Long-term effects of weight-reducing drugs in people with hypertension. Siebenhofer A; Jeitler K; Horvath K; Berghold A; Posch N; Meschik J; Semlitsch T Cochrane Database Syst Rev; 2016 Mar; 3():CD007654. PubMed ID: 26934640 [TBL] [Abstract][Full Text] [Related]
9. Current and emerging pharmacotherapies for obesity in Australia. Hocking S; Dear A; Cowley MA Obes Res Clin Pract; 2017; 11(5):501-521. PubMed ID: 28818558 [TBL] [Abstract][Full Text] [Related]
10. Recent advancements in drug treatment of obesity. Carter R; Mouralidarane A; Ray S; Soeda J; Oben J Clin Med (Lond); 2012 Oct; 12(5):456-60. PubMed ID: 23101148 [TBL] [Abstract][Full Text] [Related]
11. Formulary management of 2 new agents: lorcaserin and phentermine/topiramate for weight loss. Kelly EM; Tungol AA; Wesolowicz LA J Manag Care Pharm; 2013 Oct; 19(8):642-54. PubMed ID: 24074010 [TBL] [Abstract][Full Text] [Related]
12. Obesity Treatment: A Focus on Pharmacotherapy of Weight Management. Patel K Orthop Nurs; 2020; 39(2):121-127. PubMed ID: 32218009 [TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy for obesity. Lee PC; Dixon J Aust Fam Physician; 2017; 46(7):472-477. PubMed ID: 28697290 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological Treatment for Obesity in Adults: An Umbrella Review. Khalil H; Ellwood L; Lord H; Fernandez R Ann Pharmacother; 2020 Jul; 54(7):691-705. PubMed ID: 31958967 [No Abstract] [Full Text] [Related]
16. Pharmacotherapy for the management of obesity. Patel D Metabolism; 2015 Nov; 64(11):1376-85. PubMed ID: 26342499 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the Efficacy of Anti-Obesity Medications in Real-World Practice. Song JE; Ko HJ; Kim AS Drug Des Devel Ther; 2024; 18():845-858. PubMed ID: 38524878 [TBL] [Abstract][Full Text] [Related]